ArticleNPJ precision oncology2024
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.
Rajat Thawani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleNPJ precision oncology2024
Rajat Thawani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.